Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

HIV Infection

Free Subscription Articles published in PLoS Med Retrieve available abstracts of 56 articles: HTML format

Single Articles

November 2023
1. GALILEYA LT, Wasmann RE, Chabala C, Rabie H, et al
   Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis.
   PLoS Med. 2023;20:e1004303.
   PubMed     Abstract available
   
   
   September 2023
2. INZAULE SC, Siedner MJ, Little SJ, Avila-Rios S, et al
   Recommendations on data sharing in HIV drug resistance research.
   PLoS Med. 2023;20:e1004293.
   PubMed     Abstract available
   
   
   
3. MAFIRAKUREVA N, Mukherjee S, de Souza M, Kelly-Cirino C, et al
   Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study.
   PLoS Med. 2023;20:e1004285.
   PubMed     Abstract available
   
   
   
4. KLINKENBERG E, Floyd S, Shanaube K, Mureithi L, et al
   Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
   PLoS Med. 2023;20:e1004278.
   PubMed     Abstract available
   
   
   August 2023
5. DOVEL K, Balakasi K, Phiri K, Shaba F, et al
   Effect of index HIV self-testing for sexual partners of clients enrolled in antiretroviral therapy (ART) programs in Malawi: A randomized controlled trial.
   PLoS Med. 2023;20:e1004270.
   PubMed     Abstract available
   
   
   July 2023
6. DARLING AM, Wang D, Perumal N, Liu E, et al
   Risk factors for inadequate and excessive gestational weight gain in 25 low- and middle-income countries: An individual-level participant meta-analysis.
   PLoS Med. 2023;20:e1004236.
   PubMed     Abstract available
   
   
   June 2023
7. DORVIL N, Rivera VR, Riviere C, Berman R, et al
   Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti.
   PLoS Med. 2023;20:e1004246.
   PubMed     Abstract available
   
   
   May 2023
8. MARTINSON NA, Nonyane BAS, Genade LP, Berhanu RH, et al
   Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial).
   PLoS Med. 2023;20:e1004237.
   PubMed     Abstract available
   
   
   April 2023
9. HENSEN B, Floyd S, Phiri MM, Schaap A, et al
   The impact of community-based, peer-led sexual and reproductive health services on knowledge of HIV status among adolescents and young people aged 15 to 24 in Lusaka, Zambia: The Yathu Yathu cluster-randomised trial.
   PLoS Med. 2023;20:e1004203.
   PubMed     Abstract available
   
   
   March 2023
10. ESHUN-WILSON I, Ford N, Mody A, Beres L, et al
    Strengthening implementation guidelines for HIV service delivery: Considerations for future evidence generation and synthesis.
    PLoS Med. 2023;20:e1004168.
    PubMed     Abstract available
    
    
    
11. GRIMSRUD A, Wilkinson L, Ehrenkranz P, Behel S, et al
    The future of HIV testing in eastern and southern Africa: Broader scope, targeted services.
    PLoS Med. 2023;20:e1004182.
    PubMed     Abstract available
    
    
    
12. WAGNER AD, Njuguna IN, Neary J, Lawley KA, et al
    Demand creation for HIV testing services: A systematic review and meta-analysis.
    PLoS Med. 2023;20:e1004169.
    PubMed     Abstract available
    
    
    February 2023
13. MATTHEWS LT, Atukunda EC, Owembabazi M, Kalyebera KP, et al
    High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study.
    PLoS Med. 2023;20:e1004088.
    PubMed     Abstract available
    
    
    January 2023
14. TURTLE L, Thorpe M, Drake TM, Swets M, et al
    Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.
    PLoS Med. 2023;20:e1004086.
    PubMed     Abstract available
    
    
    
15. YANG L, Boily MC, Ronn MM, Obiri-Yeboah D, et al
    Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000-2020).
    PLoS Med. 2023;20:e1004143.
    PubMed     Abstract available
    
    
    
16. MARLEY G, Zou X, Nie J, Cheng W, et al
    Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions.
    PLoS Med. 2023;20:e1004091.
    PubMed     Abstract available
    
    
    
17. KOPO M, Lejone TI, Tschumi N, Glass TR, et al
    Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: The PEBRA cluster-randomized trial.
    PLoS Med. 2023;20:e1004150.
    PubMed     Abstract available
    
    
    
18. HENSLEY KS, Jongkees MJ, Geers D, GeurtsvanKessel CH, et al
    Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
    PLoS Med. 2023;20:e1004159.
    PubMed     Abstract available
    
    
    December 2022
19. SILVA S, Ayoub HH, Johnston C, Atun R, et al
    Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: A modeling study.
    PLoS Med. 2022;19:e1003938.
    PubMed     Abstract available
    
    
    
20. KAAYA S, Siril H, Fawzi MCS, Aloyce Z, et al
    A peer-facilitated psychological group intervention for perinatal women living with HIV and depression in Tanzania-Healthy Options: A cluster-randomized controlled trial.
    PLoS Med. 2022;19:e1004112.
    PubMed     Abstract available
    
    
    November 2022
21. 
    Correction: HIV prevention for the next decade: Appropriate, person-centred, prioritised, effective, combination prevention.
    PLoS Med. 2022;19:e1004131.
    PubMed     Abstract available
    
    
    October 2022
22. HENSLEY KS, Jongkees MJ, Geers D, GeurtsvanKessel CH, et al
    Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
    PLoS Med. 2022;19:e1003979.
    PubMed     Abstract available
    
    
    September 2022
23. GODFREY-FAUSSETT P, Frescura L, Abdool-Karim Q, Clayton M, et al
    HIV prevention for the next decade: Appropriate, person-centred, prioritised, effective, combination prevention.
    PLoS Med. 2022;19:e1004102.
    PubMed     Abstract available
    
    
    
24. TAPSOBA JD, Cover J, Obong'o C, Brady M, et al
    Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
    PLoS Med. 2022;19:e1004097.
    PubMed     Abstract available
    
    
    
25. PONS-DURAN C, Mombo-Ngoma G, Macete E, Desai M, et al
    Burden of malaria in pregnancy among adolescent girls compared to adult women in 5 sub-Saharan African countries: A secondary individual participant data meta-analysis of 2 clinical trials.
    PLoS Med. 2022;19:e1004084.
    PubMed     Abstract available
    
    
    
26. EDMONDS A, Brazier E, Musick BS, Yotebieng M, et al
    Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study.
    PLoS Med. 2022;19:e1004089.
    PubMed     Abstract available
    
    
    August 2022
27. VOJNOV L, Carmona S, Zeh C, Markby J, et al
    The performance of using dried blood spot specimens for HIV-1 viral load testing: A systematic review and meta-analysis.
    PLoS Med. 2022;19:e1004076.
    PubMed     Abstract available
    
    
    
28. WANG C, Ong JJ, Zhao P, Weideman AM, et al
    Correction: Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial.
    PLoS Med. 2022;19:e1004071.
    PubMed     Abstract available
    
    
    June 2022
29. NSENGIYUMVA NP, Campbell JR, Oxlade O, Vesga JF, et al
    Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
    PLoS Med. 2022;19:e1004032.
    PubMed     Abstract available
    
    
    
30. TAKUVA S, Takalani A, Seocharan I, Yende-Zuma N, et al
    Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
    PLoS Med. 2022;19:e1004024.
    PubMed     Abstract available
    
    
    May 2022
31. MARTIN CA, Pan D, Melbourne C, Teece L, et al
    Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.
    PLoS Med. 2022;19:e1004015.
    PubMed     Abstract available
    
    
    April 2022
32. SUDFELD CR, Manji KP, Muhihi A, Duggan CP, et al
    Vitamin D3 supplementation during pregnancy and lactation for women living with HIV in Tanzania: A randomized controlled trial.
    PLoS Med. 2022;19:e1003973.
    PubMed     Abstract available
    
    
    March 2022
33. LE TOURNEAU N, German A, Thompson R, Ford N, et al
    Evaluation of HIV treatment outcomes with reduced frequency of clinical encounters and antiretroviral treatment refills: A systematic review and meta-analysis.
    PLoS Med. 2022;19:e1003959.
    PubMed     Abstract available
    
    
    
34. WANG C, Ong JJ, Zhao P, Weideman AM, et al
    Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial.
    PLoS Med. 2022;19:e1003930.
    PubMed     Abstract available
    
    
    
35. MIRZAZADEH A, Eshun-Wilson I, Thompson RR, Bonyani A, et al
    Interventions to reengage people living with HIV who are lost to follow-up from HIV treatment programs: A systematic review and meta-analysis.
    PLoS Med. 2022;19:e1003940.
    PubMed     Abstract available
    
    
    February 2022
36. LYONS C, Bendaud V, Bourey C, Erkkola T, et al
    Global assessment of existing HIV and key population stigma indicators: A data mapping exercise to inform country-level stigma measurement.
    PLoS Med. 2022;19:e1003914.
    PubMed     Abstract available
    
    
    
37. ZHOU Y, Lu Y, Ni Y, Wu D, et al
    Monetary incentives and peer referral in promoting secondary distribution of HIV self-testing among men who have sex with men in China: A randomized controlled trial.
    PLoS Med. 2022;19:e1003928.
    PubMed     Abstract available
    
    
    January 2022
38. FOO C, Shrestha P, Wang L, Du Q, et al
    Integrating tuberculosis and noncommunicable diseases care in low- and middle-income countries (LMICs): A systematic review.
    PLoS Med. 2022;19:e1003899.
    PubMed     Abstract available
    
    
    
39. SIMMS V, Weiss HA, Chinoda S, Mutsinze A, et al
    Peer-led counselling with problem discussion therapy for adolescents living with HIV in Zimbabwe: A cluster-randomised trial.
    PLoS Med. 2022;19:e1003887.
    PubMed     Abstract available
    
    
    
40. RODI P, Obermeyer W, Pablos-Mendez A, Gori A, et al
    Political rationale, aims, and outcomes of health-related high-level meetings and special sessions at the UN General Assembly: A policy research observational study.
    PLoS Med. 2022;19:e1003873.
    PubMed     Abstract available
    
    
    
41. HODGINS C, Stannah J, Kuchukhidze S, Zembe L, et al
    Population sizes, HIV prevalence, and HIV prevention among men who paid for sex in sub-Saharan Africa (2000-2020): A meta-analysis of 87 population-based surveys.
    PLoS Med. 2022;19:e1003861.
    PubMed     Abstract available
    
    
    December 2021
42. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Coyle P, et al
    Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
    PLoS Med. 2021;18:e1003879.
    PubMed     Abstract available
    
    
    
43. SEMITALA FC, Kadota JL, Musinguzi A, Nabunje J, et al
    Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
    PLoS Med. 2021;18:e1003875.
    PubMed     Abstract available
    
    
    
44. KARUNA S, Li SS, Grant S, Walsh SR, et al
    Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.
    PLoS Med. 2021;18:e1003868.
    PubMed     Abstract available
    
    
    November 2021
45. STONER MCD, Kilburn K, Godfrey-Faussett P, Ghys P, et al
    Cash transfers for HIV prevention: A systematic review.
    PLoS Med. 2021;18:e1003866.
    PubMed     Abstract available
    
    
    
46. NDLOVU Z, Ellman T
    Lay testing cadres and point-of-care diagnostic tests for HIV and other diseases: An essential combination in health service delivery.
    PLoS Med. 2021;18:e1003867.
    PubMed     Abstract available
    
    
    
47. MARTIN CA, Marshall C, Patel P, Goss C, et al
    SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
    PLoS Med. 2021;18:e1003823.
    PubMed     Abstract available
    
    
    
48. BULSTRA CA, Hontelez JAC, Otto M, Stepanova A, et al
    Integrating HIV services and other health services: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003836.
    PubMed     Abstract available
    
    
    
49. HONTELEZ JAC, Bulstra CA, Yakusik A, Lamontagne E, et al
    Evidence-based policymaking when evidence is incomplete: The case of HIV programme integration.
    PLoS Med. 2021;18:e1003835.
    PubMed     Abstract available
    
    
    October 2021
50. BIRDTHISTLE I, Kwaro D, Shahmanesh M, Baisley K, et al
    Evaluating the impact of DREAMS on HIV incidence among adolescent girls and young women: A population-based cohort study in Kenya and South Africa.
    PLoS Med. 2021;18:e1003837.
    PubMed     Abstract available
    
    
    
51. AMSTUTZ A, Lejone TI, Khesa L, Kopo M, et al
    Offering ART refill through community health workers versus clinic-based follow-up after home-based same-day ART initiation in rural Lesotho: The VIBRA cluster-randomized clinical trial.
    PLoS Med. 2021;18:e1003839.
    PubMed     Abstract available
    
    
    
52. STOVER J, Glaubius R, Teng Y, Kelly S, et al
    Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    PLoS Med. 2021;18:e1003831.
    PubMed     Abstract available
    
    
    
53. BARRY H, Mutua G, Kibuuka H, Anywaine Z, et al
    Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
    PLoS Med. 2021;18:e1003813.
    PubMed     Abstract available
    
    
    
54. GENG EH, Reid MJA, Goosby E, Abdool-Karim Q, et al
    COVID-19 and global equity for health: The good, the bad, and the wicked.
    PLoS Med. 2021;18:e1003797.
    PubMed     Abstract available
    
    
    September 2021
55. NAGATA JM, Epstein A, Ganson KT, Benmarhnia T, et al
    Drought and child vaccination coverage in 22 countries in sub-Saharan Africa: A retrospective analysis of national survey data from 2011 to 2019.
    PLoS Med. 2021;18:e1003678.
    PubMed     Abstract available
    
    
    
56. ZULAIKA G, Nyothach E, van Eijk AM, Obor D, et al
    Factors associated with the prevalence of HIV, HSV-2, pregnancy, and reported sexual activity among adolescent girls in rural western Kenya: A cross-sectional analysis of baseline data in a cluster randomized controlled trial.
    PLoS Med. 2021;18:e1003756.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.